Page 3 - Foralumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Foralumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Foralumab Today - Breaking & Trending Today

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the Preserving the Brain Scientific Conference and Exhibit at Prada Rong Zhai in Shanghai

Exhibition will run from March 31st to May 21st, 2023, at Prada Rong ZhaiScientific Conference will be held on April 20th, 2023, at Prada Rong Zhai NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) ....

Prada Rong Zhai , Irina Koffler , Gabriele Cerrone , Fondazione Prada , Rong Zhai , Paul Spencer , Lifesci Advisors , Tiziana Life Sciences Ltd , Tiziana Life Sciences , Business Development , Prada Rong , Life Sciences , Executive Chairman , Chief Executive Officer , Tiziana Life , Investor Relations , Sci Advisors ,

Tiziana Life Sciences Announces Invitation for Podium

Dr. Saef Izzy’s data shows one-month behavioral outcomes improvement in model of intracerebral hemorrhage (hemorrhagic stroke)Modulation of. ....

United States , Mattheww Davis , Paul Spencer , Saef Izzy , Howardl Weiner , Irina Koffler , Business Development , Professor Of Neurology At Harvard Medical School , American Academy Of Neurology , Ann Romney Center , Tiziana Life Sciences Ltd , Lifesci Advisors , Tiziana Life Sciences , Life Sciences , Neurocritical Care Scientific Platform Session , Annual American Academy , Neurocritical Care , Mass General Brigham , Assistant Professor , Harvard Medical School , American Academy , Neurologic Diseases , Scientific Advisory Board , Chief Medical Officer , Tiziana Life , Investor Relations ,

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Additional Clinical Improvements in the Second Patient with Non-Active Secondary Progressive Multiple Sclerosis (SPMS) After Eleven Months of Dosing with Intranasal Foralumab

The second Expanded Access patient (EA2) demonstrated additional clinical improvement in the Expanded Disability Status Scale (EDSS), a FDA recognized standard clinical outcome assessment score NEW ....

Irina Koffler , Hana Malik , Howardl Weiner , Gabriele Cerrone , Tanuja Chitnis , Tiziana Life Sciences , Lifesci Advisors , Tiziana Life Sciences Ltd , Drug Administration , Ann Romney Center , Business Development , Expanded Access , Expanded Disability Status Scale , Life Sciences , Neurologic Diseases , Scientific Advisory Board , Executive Chairman , Chief Executive Officer , Investor Relations , Sci Advisors ,

Tiziana Life Sciences : News Service Announcement, dated November 23, 2022 - Form 6-K

Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory. | November 23, 2022 ....

New York , United States , Womens Hospital , Irina Koffler , Matthew Davis , Hana Malik , Intranasal Administration Of Foralumab Demonstrating Modulated Effector , Tiziana Life Sciences , Lifesci Advisors , Tiziana Life Sciences Ltd , Harvard Medical School , Business Development , Tiziana Announces Publication , Peer Reviewed Article , Intranasal Administration , Foralumab Demonstrating Modulated Effector , Inducedt Cell Regulatory Response , Life Sciences , Harvard Medical , Cell Sorting , Chief Medical Officer , Secondary Progressive Multiple Sclerosis , Investor Relations Manager , Sci Advisors , Tiziana Life Sciences Ltd Stock Exchange , Press Release ,

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Announces Near-Term Strategic Focus on Intranasal Foralumab for Diseases of the Central Nervous System (CNS)

-Company to host conference call via webcast at 10 am ET-NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) Tiziana Life Sciences Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing ....

Irina Koffler , Hana Malik , Gabriele Cerrone , Mattheww Davis , Tiziana Life Sciences , Lifesci Advisors , Tiziana Life Sciences Ltd , Business Development , Access Program , Life Sciences , Central Nervous System , Multiple Sclerosis , Executive Chairman , Chief Executive Officer , Chief Medical Officer , Expanded Access Program , Investor Relations , Sci Advisors ,